2012
Psychiatrist Decision-Making Towards Prescribing Benzodiazepines: The Dilemma with Substance Abusers
Marienfeld CB, Tek E, Diaz E, Schottenfeld R, Chawarski M. Psychiatrist Decision-Making Towards Prescribing Benzodiazepines: The Dilemma with Substance Abusers. Psychiatric Quarterly 2012, 83: 521-529. PMID: 22528141, DOI: 10.1007/s11126-012-9220-8.Peer-Reviewed Original ResearchMeSH KeywordsAdultBenzodiazepinesComorbidityDecision MakingDrug PrescriptionsHumansMental DisordersPsychiatrySubstance-Related DisordersWorkforceConceptsMental health centersPrescribing benzodiazepinesHealth centersPublic mental health centersSubstance abuseCommunity mental health centerUse of benzodiazepinesPercent of responsesOutpatient psychiatristsPatient characteristicsUnknown patientsPatient historyCommon reasonPatient useHistory of abuseBenzodiazepinesIllicit substancesSubstance abusersAnonymous surveyPatientsPsychiatristsPsychiatrists' decisionsAbusePrevious studies
2010
Whether medically unexplained or not, three or more concurrent somatic symptoms predict psychopathology and service use in community populations
Escobar JI, Cook B, Chen CN, Gara MA, Alegría M, Interian A, Diaz E. Whether medically unexplained or not, three or more concurrent somatic symptoms predict psychopathology and service use in community populations. Journal Of Psychosomatic Research 2010, 69: 1-8. PMID: 20630257, PMCID: PMC2905311, DOI: 10.1016/j.jpsychores.2010.01.001.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAnxiety DisordersAsianCommunity Health ServicesComorbidityCross-Cultural ComparisonDepressive DisorderFemaleHispanic or LatinoHumansMaleMental DisordersMiddle AgedSomatoform DisordersStatistics as TopicSubstance-Related DisordersUtilization ReviewWhite PeopleYoung AdultConceptsGeneral physical symptomsPhysical symptomsService useSomatic symptomsCommunity populationUse of servicesPsychological distressCommon mental disordersUnexplained physical symptomsSubstance use disordersSignificant independent effectUnadjusted comparisonsPsychiatric disordersUse disordersMental disordersSymptomsMUPSSignificant predictorsIndependent effectsMedical explanationDisordersMultivariate regressionRegression analysisOne-thirdDistress
2000
Characteristics of Participants and Nonparticipants in Medication Trials for Treatment of Schizophrenia
Woods SW, Ziedonis DM, Sernyak MJ, Diaz E, Rosenheck RA. Characteristics of Participants and Nonparticipants in Medication Trials for Treatment of Schizophrenia. Psychiatric Services 2000, 51: 79-84. PMID: 10647137, DOI: 10.1176/ps.51.1.79.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntipsychotic AgentsClinical Trials as TopicFemaleHumansMalePatient ParticipationSchizophreniaSubstance-Related DisordersTreatment OutcomeConceptsSubstance use disordersTreatment of schizophreniaUse disordersAdministrative databasesEfficacy trialsTrial participantsDual diagnosisConcurrent substance use disordersCommunity mental health centerTreatment Efficacy TrialCharacteristics of patientsPoor treatment outcomesMental health centersCharacteristics of participantsMedical comorbiditiesMedication trialsTypes of trialsMale genderHealth centersService utilizationTreatment outcomesBetter outcomesPatientsTreatment efficacyYounger age